neuralgap.io

A Quick update: Our Multi-Unimodal Model Paper has been published on ISBI 2025.

Our Paper on our Multi-Unimodal Model architecture has been published in ISBI!
https://ieeexplore.ieee.org/document/10981182

Bioforager

End-to-End Virtual Screening for Researchers, Powered by Genesys

Coming Soon

Biosentinel

Supporting Biotech Investment Analysts with industry insights

Coming Soon

Genesys | Quantum Aware Multi-modal Engine

Genesys is a multi-modal AI model that can predict binding affinity, model trajectories and inference bioactivity

Unified Processing

Seamless integration of multiple molecular representations
Real-time synchronization of structural and dynamic data
Advanced pattern recognition across binding modalities

Adaptive Learning

Training on unpaired, asynchronous molecular data
Continuous improvement from real-world screening results
Flexible adaptation to discovery workflows

Intelligent Scaling

More than 50% reduction in computational parameters
Superior accuracy with fewer training compounds
Seamless integration of new molecular descriptors

Learn About Genesys

Need Support Implementing Deep Learning?

Neuralgap supports custom deep learning builds for Pharma clients.

Interactive image may take a moment to download

Target Identification & Validation

AI-driven genomics data analysis
Natural language processing for literature mining

Interactive image may take a moment to download

Hit Discovery & Optimization

AI-powered virtual screening
Structure-based virtual screening using deep learning
Machine learning for ADMET prediction
Molecular dynamics simulations with GPU acceleration

Interactive image may take a moment to download

Lead Optimization & Candidate Selection

Quantitative structure-activity relationship (QSAR) modeling using AI
AI-driven toxicity prediction and safety assessment

Learn More

Our Articles

Follow our weekly article series to keep track of the latest advances in AI in bio and cheminformatics

All Posts
Biotech

Unsupervised ML in Drug Discovery (I): Intro

Unsupervised ML in Drug Discovery (I): Intro Drug discovery is a challenging process, primarily due to the vast combinatorial chemical…

QSAR of Small Molecule Drugs: The Use of Neural Networks

QSAR of Small Molecule Drugs: The Use of Neural Networks Quantitative Structure-Activity Relationships (QSAR), the cornerstone of modern drug discovery,…

HMMs vs MSMs: Divergent Applications in Bioinformatics and Cheminformatics

HMMs vs MSMs: Divergent Applications in Bioinformatics and Cheminformatics From decoding the hidden messages in DNA to predicting the fluid…

End of Content.

End-to-End Virtual Screening for Pharma Researchers.

Bioforager

End-to-End Virtual Screening for Researchers, Powered by Genesys

Biosentinel

Supporting Biotech Investment Analysts with industry insights

Genesys | Quantum Aware Multi-modal Engine

Genesys is a multi-modal AI model that can predict binding affinity, model trajectories and inference bioactivity

Need Support Implementing Deep Learning?

Neuralgap supports custom deep learning builds for Pharma clients.

Our Articles

Follow our weekly article series to keep track of the latest advances in AI in bio and cheminformatics

Get in Touch!